Fortunato Ron Rocca's most recent trade in Exagen Inc was a trade of 4,322 Common Stock done at an average price of $7.1 . Disclosure was reported to the exchange on March 1, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exagen Inc | Fortunato Ron Rocca | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.12 per share. | 01 Mar 2022 | 4,322 | 120,678 (0%) | 0% | 7.1 | 30,773 | Common Stock |
| Exagen Inc | Fortunato Ron Rocca | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 75,000 | 125,000 (0%) | 0% | 0 | Common Stock | |
| Exagen Inc | Fortunato Ron Rocca | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Exagen Inc | Fortunato Ron Rocca | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 40,000 | 40,000 | - | - | Stock Option(right to buy) |